BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6844664)

  • 1. Basal hyperchlorhydria and its relation to the plasma concentrations of secretin, vasoactive intestinal polypeptide (VIP) and gastrin during prolonged strain.
    Oektedalen O; Opstad PK; Schaffalitzky de Muckadell OB; Fausa O; Flaten O
    Regul Pept; 1983 Feb; 5(3):235-44. PubMed ID: 6844664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma concentration of vasoactive intestinal polypeptide during prolonged physical exercise, calorie supply deficiency, and sleep deprivation.
    Oktedalen O; Opstad PK; Fahrenkrug J; Fonnum F
    Scand J Gastroenterol; 1983 Nov; 18(8):1057-62. PubMed ID: 6673075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The plasma concentrations of secretin and vasoactive intestinal polypeptide (VIP) after long-term, strenuous exercise.
    Oktedalen O; Opstad PK; Schaffalitzky de Muckadell OB
    Eur J Appl Physiol Occup Physiol; 1983; 52(1):5-8. PubMed ID: 6686128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretin--a new stress hormone?
    Oektedalen O; Opstad PK; Schaffalitzky de Muckadell OB
    Regul Pept; 1982 Sep; 4(4):213-9. PubMed ID: 7146493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fasting levels and the postprandial response of gastroenteropancreatic hormones before and after prolonged fasting.
    Oktedalen O; Opstad PK; Waldum H; Jorde R
    Scand J Gastroenterol; 1983 May; 18(4):555-60. PubMed ID: 6669932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of gastrin on circulating levels of somatostatin, pancreatic polypeptide, and vasoactive intestinal peptide in dogs.
    Guzman S; Lonovics J; Chayvialle JA; Hejtmancik KE; Rayford PL; Thompson JC
    Endocrinology; 1980 Jul; 107(1):231-6. PubMed ID: 6103802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cimetidine fails to suppress the rise in plasma secretin during fasting.
    Bell PM; Henry RW; Buchanan KD; Alberti KG
    Regul Pept; 1985 Mar; 10(2-3):127-31. PubMed ID: 3991916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responses of vasoactive intestinal polypeptide, secretin, and human pancreatic polypeptide to glucose during fasting.
    Oktedalen O; Opstad PK; Jorde R; Schaffalitzky de Muckadell OB
    Scand J Gastroenterol; 1984 Jan; 19(1):59-64. PubMed ID: 6710078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of vasoactive intestinal peptide (VIP) and secretin in gastric secretion and mucosal blood flow.
    Konturek SJ; Dembiński A; Thor P; Król R
    Pflugers Arch; 1976 Jan; 361(2):175-81. PubMed ID: 765958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of a test meal on plasma vasoactive intestinal polypeptide (VIP), gastric inhibitory polypeptide (GIP), and secretin in man.
    Burhol PG; Waldum HL; Jorde R; Lygren I
    Scand J Gastroenterol; 1979; 14(8):939-43. PubMed ID: 531513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fasting and prolonged exercise increase vasoactive intestinal polypeptide (VIP) in plasma.
    Galbo H; Hilsted J; Fahrenkrug J; Schaffalitzky De Muckadell OB
    Acta Physiol Scand; 1979 Mar; 105(3):374-7. PubMed ID: 443066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous recording of the gastro-entero-pancreatic hormonal peptide response to food in man.
    Hornnes PJ; Kühl C; Holst JJ; Lauritsen KB; Rehfeld JF; Schwartz TW
    Metabolism; 1980 Aug; 29(8):777-9. PubMed ID: 6995794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of vagal stimulation on pancreatic secretion and on blood levels of gastrin, cholecystokinin, secretin, vasoactive intestinal peptide, and somatostatin.
    Guzman S; Chayvialle JA; Banks WA; Rayford PL; Thompson JC
    Surgery; 1979 Aug; 86(2):329-36. PubMed ID: 462378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The gastro-entero-pancreatic hormone response to fasting in obesity.
    Andrews WJ; Henry RW; Alberti KG; Buchanan KD
    Diabetologia; 1981 Nov; 21(5):440-5. PubMed ID: 7028557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastroenteropancreatic hormonal changes during exercise.
    Hilsted J; Galbo H; Sonne B; Schwartz T; Fahrenkrug J; de Muckadell OB; Lauritsen KB; Tronier B
    Am J Physiol; 1980 Sep; 239(3):G136-40. PubMed ID: 6108073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum group I pepsinogens during prolonged infusion of pentagastrin and secretin in man.
    Waldum HL; Burhol PG; Straume BK
    Scand J Gastroenterol; 1979; 14(6):761-8. PubMed ID: 43586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of vasoactive intestinal polypeptide (VIP), secretin and gastrin on insulin secretion in the mouse.
    Ahrén B; Lundquist I
    Diabetologia; 1981; 20(1):54-9. PubMed ID: 7009286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of secretin on postprandial gastrin release in the dog: a further study.
    Kim YC; Lee KY; Chey WY
    Surgery; 1981 Sep; 90(3):504-8. PubMed ID: 7268628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of meal and cimetidine on endogenous plasma gastrin, secretin and pancreatic polypeptide in experimental acid hypersecretion in dogs.
    Koizumi F; Ushizawa R; Kawamura T; Ishimori A; Sasaki I; Kameyama J
    Tohoku J Exp Med; 1984 May; 143(1):17-25. PubMed ID: 6464010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoactive intestinal peptide-associated inhibition of stimulated gastric secretion. II. Inhibition of pentagastrin-stimulated gastric secretion.
    Escourrou J; Ebeid AM; Fischer JE
    Am J Surg; 1980 Jun; 139(6):824-8. PubMed ID: 7386737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.